1 |
SIGMAR1
💬
| 2件: Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Pathways of neurodegeneration - multiple diseases | Dextromethorphan
Dextromethorphan
💬
|
Dextromethorphan
| 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬 |
2 |
IL17F
💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Inflammatory bowel disease | Bimekizumab
Bimekizumab
💬
|
Bimekizumab
| 3件: 46 46, 97, 271 💬 |
3 |
TPH2
💬
| 4件: Tryptophan metabolism Tryptophan metabolism, Folate biosynthesis, Metabolic pathways, Serotonergic synapse | Telotristat
Telotristat
💬
|
Telotristat
| 1件: 97 97 💬 |
4 |
CNR1
💬
| 4件: Rap1 signaling pathway Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Retrograde endocannabinoid signaling | Cannabidiol
Cannabidiol
💬
|
Cannabidiol
| 20件: 2 2, 6, 8, 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 |
5 |
CNR2
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Cannabidiol
Cannabidiol
💬
|
Cannabidiol
| 20件: 2 2, 6, 8, 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 |
6 |
ADORA1
💬
| 7件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, cAMP signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction | Caffeine
Caffeine
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
7 |
ADORA1
💬
| 7件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, cAMP signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction | Caffeine hydrate
Caffeine hydrate
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
8 |
ADORA2A
💬
| 7件: Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease, Alcoholism | Caffeine
Caffeine
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
9 |
ADORA2A
💬
| 7件: Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease, Alcoholism | Caffeine hydrate
Caffeine hydrate
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
10 |
CSF2RA
💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer | Molgramostim
Molgramostim
💬
|
Molgramostim
| 3件: 97 97, 229, 299 💬 |
11 |
ACE
💬
| 6件: Renin-angiotensin system Renin-angiotensin system, Renin secretion, Chagas disease, Coronavirus disease - COVID-19, Hypertrophic cardiomyopathy, Diabetic cardiomyopathy | Captopril
Captopril
💬
|
Captopril
| 8件: 6 6, 17, 46, 86, 96, 97, 107, 271 💬 |
12 |
HTR3C
💬
| 2件: Serotonergic synapse Serotonergic synapse, Taste transduction | Ondansetron
Ondansetron
💬
|
Ondansetron
| 3件: 6 6, 97, 107 💬 |
13 |
DHFR
💬
| 5件: One carbon pool by folate One carbon pool by folate, Folate biosynthesis, Metabolic pathways, Biosynthesis of cofactors, Antifolate resistance | Methotrexate
Methotrexate
💬
|
Methotrexate
| 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬 |
14 |
DRD1
💬
| 10件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Amphetamine addiction, Morphine addiction, Alcoholism | Flupentixol
Flupentixol
💬
|
Flupentixol
| 1件: 97 97 💬 |
15 |
DRD2
💬
| 8件: Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism | Flupentixol
Flupentixol
💬
|
Flupentixol
| 1件: 97 97 💬 |
16 |
AGTR1
💬
| 16件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Apelin signaling pathway, Renin-angiotensin system, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, AGE-RAGE signaling pathway in diabetic complications, Cushing syndrome, Coronavirus disease - COVID-19, Pathways in cancer, Diabetic cardiomyopathy | Losartan
Losartan
💬
|
Losartan
| 17件: 17 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
17 |
S1PR1
💬
| 3件: FoxO signaling pathway FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Amiselimod
Amiselimod
💬
|
Amiselimod
| 1件: 97 97 💬 |
18 |
S1PR1
💬
| 3件: FoxO signaling pathway FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Etrasimod
Etrasimod
💬
|
Etrasimod
| 3件: 96 96, 97, 98 💬 |
19 |
S1PR1
💬
| 3件: FoxO signaling pathway FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Ozanimod
Ozanimod
💬
|
Ozanimod
| 3件: 13 13, 96, 97 💬 |
20 |
S1PR3
💬
| 2件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Amiselimod
Amiselimod
💬
|
Amiselimod
| 1件: 97 97 💬 |
21 |
S1PR3
💬
| 2件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Etrasimod
Etrasimod
💬
|
Etrasimod
| 3件: 96 96, 97, 98 💬 |
22 |
S1PR3
💬
| 2件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Ozanimod
Ozanimod
💬
|
Ozanimod
| 3件: 13 13, 96, 97 💬 |
23 |
DHFR2
💬
| 5件: One carbon pool by folate One carbon pool by folate, Folate biosynthesis, Metabolic pathways, Biosynthesis of cofactors, Antifolate resistance | Methotrexate
Methotrexate
💬
|
Methotrexate
| 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬 |
24 |
HTR3D
💬
| 2件: Serotonergic synapse Serotonergic synapse, Taste transduction | Ondansetron
Ondansetron
💬
|
Ondansetron
| 3件: 6 6, 97, 107 💬 |
25 |
GABRA1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
26 |
GABRA1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
27 |
GABRA1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
28 |
GABRA2
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
29 |
GABRA2
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
30 |
GABRA2
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
31 |
GABRA3
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
32 |
GABRA3
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
33 |
GABRA3
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
34 |
GABRA4
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
35 |
GABRA4
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
36 |
GABRA4
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
37 |
GABRA5
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
38 |
GABRA5
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
39 |
GABRA5
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
40 |
GABRA6
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
41 |
GABRA6
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
42 |
GABRA6
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
43 |
GABRB1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
44 |
GABRB1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
45 |
GABRB1
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
46 |
GABRB2
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
47 |
GABRB2
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
48 |
GABRB2
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
49 |
GABRB3
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
50 |
GABRB3
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
51 |
GABRB3
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
52 |
GABRD
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
53 |
GABRD
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
54 |
GABRD
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
55 |
GABRE
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
56 |
GABRE
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
57 |
GABRE
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
58 |
GABRG1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
59 |
GABRG1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
60 |
GABRG1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
61 |
GABRG2
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
62 |
GABRG2
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
63 |
GABRG2
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
64 |
GABRG3
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
65 |
GABRG3
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
66 |
GABRG3
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
67 |
GABRP
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
68 |
GABRP
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
69 |
GABRP
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
70 |
HTR3E
💬
| 2件: Serotonergic synapse Serotonergic synapse, Taste transduction | Ondansetron
Ondansetron
💬
|
Ondansetron
| 3件: 6 6, 97, 107 💬 |
71 |
GRIA1
💬
| 14件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Long-term depression, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
72 |
GRIA2
💬
| 15件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Long-term depression, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
73 |
GRIA3
💬
| 13件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Long-term depression, Huntington disease, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Nicotine addiction, Transcriptional misregulation in cancer | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
74 |
GRIA4
💬
| 10件: cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Huntington disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
75 |
GRIK1
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Glutamatergic synapse | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
76 |
GRIK2
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Glutamatergic synapse | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
77 |
GRIK3
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Glutamatergic synapse | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
78 |
GRIK4
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Glutamatergic synapse | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
79 |
GRIK5
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Glutamatergic synapse | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
80 |
GRIN1
💬
| 18件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Dextromethorphan
Dextromethorphan
💬
|
Dextromethorphan
| 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬 |
81 |
GRIN2A
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Dextromethorphan
Dextromethorphan
💬
|
Dextromethorphan
| 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬 |
82 |
GRIN2B
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Dextromethorphan
Dextromethorphan
💬
|
Dextromethorphan
| 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬 |
83 |
GRIN2C
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Dextromethorphan
Dextromethorphan
💬
|
Dextromethorphan
| 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬 |
84 |
GRIN2D
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Dextromethorphan
Dextromethorphan
💬
|
Dextromethorphan
| 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬 |
85 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Hydrocortisone
Hydrocortisone
💬
|
Hydrocortisone
| 10件: 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 💬 |
86 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Hydrocortisone acetate
Hydrocortisone acetate
💬
|
Hydrocortisone acetate
| 1件: 97 97 💬 |
87 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Budesonide
Budesonide
💬
|
Budesonide
| 9件: 66 66, 93, 94, 95, 96, 97, 98, 228, 299 💬 |
88 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Dexamethasone
Dexamethasone
💬
|
Dexamethasone
| 22件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬 |
89 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Methylprednisolone
Methylprednisolone
💬
|
Methylprednisolone
| 46件: 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
90 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Prednisolone
Prednisolone
💬
|
Prednisolone
| 42件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
91 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Prednisone
Prednisone
💬
|
Prednisone
| 45件: 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬 |
92 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Beclomethasone dipropionate
Beclomethasone dipropionate
💬
|
Beclomethasone dipropionate
| 3件: 85 85, 97, 98 💬 |
93 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Methylprednisolone hemisuccinate
Methylprednisolone hemisuccinate
💬
|
Methylprednisolone hemisuccinate
| 7件: 13 13, 49, 50, 51, 53, 97, 211 💬 |
94 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Vamorolone
Vamorolone
💬
|
Vamorolone
| 2件: 97 97, 113 💬 |
95 |
GUCY2C
💬
| 2件: Purine metabolism Purine metabolism, Metabolic pathways | Linaclotide
Linaclotide
💬
|
Linaclotide
| 2件: 6 6, 97 💬 |
96 |
HMGCR
💬
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, AMPK signaling pathway, Bile secretion | Atorvastatin
Atorvastatin
💬
|
Atorvastatin
| 19件: 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬 |
97 |
HMGCR
💬
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, AMPK signaling pathway, Bile secretion | Rosuvastatin
Rosuvastatin
💬
|
Rosuvastatin
| 11件: 6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
98 |
HPRT1
💬
| 4件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism | Mercaptopurine
Mercaptopurine
💬
|
Mercaptopurine
| 4件: 65 65, 96, 97, 164 💬 |
99 |
HPRT1
💬
| 4件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism | Mercaptopurine
Mercaptopurine
💬
|
Mercaptopurine
| 4件: 65 65, 96, 97, 164 💬 |
100 |
HTR3A
💬
| 2件: Serotonergic synapse Serotonergic synapse, Taste transduction | Ondansetron
Ondansetron
💬
|
Ondansetron
| 3件: 6 6, 97, 107 💬 |
101 |
IFNAR1
💬
| 18件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Hepatitis C, Hepatitis B, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer | Interferon beta-1a
Interferon beta-1a
💬
|
Interferon beta-1a
| 4件: 13 13, 26, 96, 97 💬 |
102 |
IFNAR2
💬
| 17件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Hepatitis C, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer | Interferon beta-1a
Interferon beta-1a
💬
|
Interferon beta-1a
| 4件: 13 13, 26, 96, 97 💬 |
103 |
IL1R1
💬
| 13件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Hematopoietic cell lineage, Th17 cell differentiation, Inflammatory mediator regulation of TRP channels, Pathogenic Escherichia coli infection, Shigellosis, Amoebiasis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Fluid shear stress and atherosclerosis | Anakinra
Anakinra
💬
|
Anakinra
| 18件: 2 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬 |
104 |
IL2RA
💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, Endocytosis, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Th1 and Th2 cell differentiation, Th17 cell differentiation, Measles, Human T-cell leukemia virus 1 infection, Pathways in cancer | Aldesleukin
Aldesleukin
💬
|
Aldesleukin
| 6件: 2 2, 35, 49, 65, 96, 97 💬 |
105 |
IL2RA
💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, Endocytosis, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Th1 and Th2 cell differentiation, Th17 cell differentiation, Measles, Human T-cell leukemia virus 1 infection, Pathways in cancer | Basiliximab
Basiliximab
💬
|
Basiliximab
| 6件: 2 2, 50, 66, 97, 222, 228 💬 |
106 |
IL2RA
💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, Endocytosis, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Th1 and Th2 cell differentiation, Th17 cell differentiation, Measles, Human T-cell leukemia virus 1 infection, Pathways in cancer | Daclizumab
Daclizumab
💬
|
Daclizumab
| 8件: 13 13, 56, 60, 65, 97, 107, 283, 284 💬 |
107 |
IL2RB
💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, Endocytosis, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Measles, Human T-cell leukemia virus 1 infection, Pathways in cancer, Transcriptional misregulation in cancer | Aldesleukin
Aldesleukin
💬
|
Aldesleukin
| 6件: 2 2, 35, 49, 65, 96, 97 💬 |
108 |
IL2RG
💬
| 12件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, Endocytosis, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Measles, Human T-cell leukemia virus 1 infection, Pathways in cancer, Inflammatory bowel disease, Primary immunodeficiency | Aldesleukin
Aldesleukin
💬
|
Aldesleukin
| 6件: 2 2, 35, 49, 65, 96, 97 💬 |
109 |
IL4R
💬
| 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Th1 and Th2 cell differentiation, Th17 cell differentiation, Pathways in cancer, Inflammatory bowel disease | Dupilumab
Dupilumab
💬
|
Dupilumab
| 5件: 51 51, 97, 98, 160, 162 💬 |
110 |
IL12A
💬
| 25件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Alcoholic liver disease, Type I diabetes mellitus, Pertussis, Legionellosis, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Pathways in cancer, Inflammatory bowel disease, Allograft rejection, Lipid and atherosclerosis | Ustekinumab
Ustekinumab
💬
|
Ustekinumab
| 16件: 37 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬 |
111 |
IL12B
💬
| 25件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Alcoholic liver disease, Type I diabetes mellitus, Pertussis, Legionellosis, Leishmaniasis, Chagas disease, African trypanosomiasis, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Pathways in cancer, Proteoglycans in cancer, Inflammatory bowel disease, Allograft rejection, Lipid and atherosclerosis | Ustekinumab
Ustekinumab
💬
|
Ustekinumab
| 16件: 37 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬 |
112 |
IL13
💬
| 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, IL-17 signaling pathway, Th1 and Th2 cell differentiation, Fc epsilon RI signaling pathway, Pathways in cancer, Asthma, Inflammatory bowel disease | Anrukinzumab
Anrukinzumab
💬
|
Anrukinzumab
| 1件: 97 97 💬 |
113 |
IL13
💬
| 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, IL-17 signaling pathway, Th1 and Th2 cell differentiation, Fc epsilon RI signaling pathway, Pathways in cancer, Asthma, Inflammatory bowel disease | Tralokinumab
Tralokinumab
💬
|
Tralokinumab
| 2件: 85 85, 97 💬 |
114 |
IL17A
💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Alcoholic liver disease, Inflammatory bowel disease, Rheumatoid arthritis | Bimekizumab
Bimekizumab
💬
|
Bimekizumab
| 3件: 46 46, 97, 271 💬 |
115 |
ITGA4
💬
| 14件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules, Hematopoietic cell lineage, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Yersinia infection, Leishmaniasis, Human papillomavirus infection, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Vedolizumab
Vedolizumab
💬
|
Vedolizumab
| 3件: 94 94, 96, 97 💬 |
116 |
ITGA4
💬
| 14件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules, Hematopoietic cell lineage, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Yersinia infection, Leishmaniasis, Human papillomavirus infection, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Abrilumab
Abrilumab
💬
|
Abrilumab
| 2件: 96 96, 97 💬 |
117 |
ITGB7
💬
| 11件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Human papillomavirus infection, Transcriptional misregulation in cancer, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Vedolizumab
Vedolizumab
💬
|
Vedolizumab
| 3件: 94 94, 96, 97 💬 |
118 |
ITGB7
💬
| 11件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Human papillomavirus infection, Transcriptional misregulation in cancer, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Etrolizumab
Etrolizumab
💬
|
Etrolizumab
| 2件: 96 96, 97 💬 |
119 |
ITGB7
💬
| 11件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Human papillomavirus infection, Transcriptional misregulation in cancer, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Abrilumab
Abrilumab
💬
|
Abrilumab
| 2件: 96 96, 97 💬 |
120 |
JAK1
💬
| 27件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis C, Hepatitis B, Measles, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer, Viral carcinogenesis, Pancreatic cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | Tofacitinib
Tofacitinib
💬
|
Tofacitinib
| 15件: 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬 |
121 |
JAK1
💬
| 27件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis C, Hepatitis B, Measles, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer, Viral carcinogenesis, Pancreatic cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | Filgotinib
Filgotinib
💬
|
Filgotinib
| 6件: 46 46, 53, 96, 97, 222, 271 💬 |
122 |
JAK1
💬
| 27件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis C, Hepatitis B, Measles, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer, Viral carcinogenesis, Pancreatic cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | Itacitinib
Itacitinib
💬
|
Itacitinib
| 4件: 46 46, 51, 97, 228 💬 |
123 |
JAK1
💬
| 27件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis C, Hepatitis B, Measles, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer, Viral carcinogenesis, Pancreatic cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | Upadacitinib
Upadacitinib
💬
|
Upadacitinib
| 8件: 40 40, 41, 46, 49, 96, 97, 107, 271 💬 |
124 |
JAK2
💬
| 24件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, Chemokine signaling pathway, PI3K-Akt signaling pathway, Necroptosis, Signaling pathways regulating pluripotency of stem cells, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Cholinergic synapse, Prolactin signaling pathway, Adipocytokine signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Growth hormone synthesis, secretion and action, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis B, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Pathways in cancer, Chemical carcinogenesis - receptor activation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tofacitinib
Tofacitinib
💬
|
Tofacitinib
| 15件: 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬 |
125 |
JAK3
💬
| 15件: Chemokine signaling pathway Chemokine signaling pathway, PI3K-Akt signaling pathway, Necroptosis, Signaling pathways regulating pluripotency of stem cells, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Hepatitis B, Measles, Human T-cell leukemia virus 1 infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis, Non-small cell lung cancer, Primary immunodeficiency | Tofacitinib
Tofacitinib
💬
|
Tofacitinib
| 15件: 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬 |
126 |
LTB
💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis | Baminercept
Baminercept
💬
|
Baminercept
| 4件: 13 13, 46, 53, 97 💬 |
127 |
SMAD7
💬
| 2件: TGF-beta signaling pathway TGF-beta signaling pathway, Hippo signaling pathway | Mongersen
Mongersen
💬
|
Mongersen
| 2件: 96 96, 97 💬 |
128 |
MAOA
💬
| 14件: Glycine, serine and threonine metabolism Glycine, serine and threonine metabolism, Arginine and proline metabolism, Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Drug metabolism - cytochrome P450, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Amphetamine addiction, Alcoholism | Phentermine
Phentermine
💬
|
Phentermine
| 1件: 97 97 💬 |
129 |
MAOB
💬
| 14件: Glycine, serine and threonine metabolism Glycine, serine and threonine metabolism, Arginine and proline metabolism, Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Drug metabolism - cytochrome P450, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Amphetamine addiction, Alcoholism | Phentermine
Phentermine
💬
|
Phentermine
| 1件: 97 97 💬 |
130 |
MTNR1A
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | Melatonin
Melatonin
💬
|
Melatonin
| 12件: 6 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 💬 |
131 |
MTNR1B
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Circadian entrainment | Melatonin
Melatonin
💬
|
Melatonin
| 12件: 6 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 💬 |
132 |
SERPINC1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Adomiparin
Adomiparin
💬
|
Parnaparin
| 1件: 97 97 💬 |
133 |
ATP4A
💬
| 4件: Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Collecting duct acid secretion, Gastric acid secretion | Omeprazole
Omeprazole
💬
|
Omeprazole
| 14件: 6 6, 8, 21, 46, 51, 85, 96, 97, 225, 271, 282, 294, 298, 299 💬 |
134 |
ATP4B
💬
| 4件: Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Collecting duct acid secretion, Gastric acid secretion | Omeprazole
Omeprazole
💬
|
Omeprazole
| 14件: 6 6, 8, 21, 46, 51, 85, 96, 97, 225, 271, 282, 294, 298, 299 💬 |
135 |
OPRD1
💬
| 3件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Naltrexone
Naltrexone
💬
|
Naltrexone
| 13件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬 |
136 |
OPRD1
💬
| 3件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Loperamide
Loperamide
💬
|
Loperamide
| 2件: 13 13, 97 💬 |
137 |
OPRK1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Naltrexone
Naltrexone
💬
|
Naltrexone
| 13件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬 |
138 |
OPRK1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Loperamide
Loperamide
💬
|
Loperamide
| 2件: 13 13, 97 💬 |
139 |
OPRM1
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | Naltrexone
Naltrexone
💬
|
Naltrexone
| 13件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬 |
140 |
OPRM1
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | Loperamide
Loperamide
💬
|
Loperamide
| 2件: 13 13, 97 💬 |
141 |
IL22
💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Th17 cell differentiation, Inflammatory bowel disease | Efmarodocokin alfa
Efmarodocokin alfa
💬
|
Efmarodocokin alfa
| 2件: 96 96, 97 💬 |
142 |
PDCD1
💬
| 3件: Cell adhesion molecules Cell adhesion molecules, T cell receptor signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer | Nivolumab
Nivolumab
💬
|
Nivolumab
| 12件: 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
143 |
PDE2A
💬
| 6件: Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, Olfactory transduction, Aldosterone synthesis and secretion, Morphine addiction | Caffeine
Caffeine
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
144 |
PDE2A
💬
| 6件: Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, Olfactory transduction, Aldosterone synthesis and secretion, Morphine addiction | Caffeine hydrate
Caffeine hydrate
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
145 |
PDE3A
💬
| 6件: Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, cAMP signaling pathway, Renin secretion, Morphine addiction | Caffeine
Caffeine
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
146 |
PDE3A
💬
| 6件: Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, cAMP signaling pathway, Renin secretion, Morphine addiction | Caffeine hydrate
Caffeine hydrate
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
147 |
PDE3B
💬
| 11件: Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, cAMP signaling pathway, Apelin signaling pathway, Insulin signaling pathway, Progesterone-mediated oocyte maturation, Glucagon signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction | Caffeine
Caffeine
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
148 |
PDE3B
💬
| 11件: Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, cAMP signaling pathway, Apelin signaling pathway, Insulin signaling pathway, Progesterone-mediated oocyte maturation, Glucagon signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction | Caffeine hydrate
Caffeine hydrate
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
149 |
PDE4A
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Caffeine
Caffeine
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
150 |
PDE4A
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Caffeine hydrate
Caffeine hydrate
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
151 |
PDE4A
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Roflumilast
Roflumilast
💬
|
Roflumilast
| 4件: 84 84, 97, 206, 299 💬 |
152 |
PDE4A
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Apremilast
Apremilast
💬
|
Apremilast
| 7件: 46 46, 50, 56, 97, 107, 162, 271 💬 |
153 |
PDE4B
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Caffeine
Caffeine
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
154 |
PDE4B
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Caffeine hydrate
Caffeine hydrate
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
155 |
PDE4B
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Roflumilast
Roflumilast
💬
|
Roflumilast
| 4件: 84 84, 97, 206, 299 💬 |
156 |
PDE4B
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Apremilast
Apremilast
💬
|
Apremilast
| 7件: 46 46, 50, 56, 97, 107, 162, 271 💬 |
157 |
PDE4C
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Caffeine
Caffeine
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
158 |
PDE4C
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Caffeine hydrate
Caffeine hydrate
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
159 |
PDE4C
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Roflumilast
Roflumilast
💬
|
Roflumilast
| 4件: 84 84, 97, 206, 299 💬 |
160 |
PDE4C
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Apremilast
Apremilast
💬
|
Apremilast
| 7件: 46 46, 50, 56, 97, 107, 162, 271 💬 |
161 |
PDE4D
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Caffeine
Caffeine
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
162 |
PDE4D
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Caffeine hydrate
Caffeine hydrate
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
163 |
PDE4D
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Roflumilast
Roflumilast
💬
|
Roflumilast
| 4件: 84 84, 97, 206, 299 💬 |
164 |
PDE4D
💬
| 5件: Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Apremilast
Apremilast
💬
|
Apremilast
| 7件: 46 46, 50, 56, 97, 107, 162, 271 💬 |
165 |
PDE1B
💬
| 7件: Purine metabolism Purine metabolism, Metabolic pathways, Calcium signaling pathway, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction | Caffeine
Caffeine
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
166 |
PDE1B
💬
| 7件: Purine metabolism Purine metabolism, Metabolic pathways, Calcium signaling pathway, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction | Caffeine hydrate
Caffeine hydrate
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
167 |
IL23A
💬
| 9件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | Ustekinumab
Ustekinumab
💬
|
Ustekinumab
| 16件: 37 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬 |
168 |
IL23A
💬
| 9件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | Guselkumab
Guselkumab
💬
|
Guselkumab
| 5件: 37 37, 41, 51, 96, 97 💬 |
169 |
IL23A
💬
| 9件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | Brazikumab
Brazikumab
💬
|
Brazikumab
| 2件: 96 96, 97 💬 |
170 |
IL23A
💬
| 9件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | Risankizumab
Risankizumab
💬
|
Risankizumab
| 4件: 37 37, 96, 97, 271 💬 |
171 |
IL23A
💬
| 9件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, C-type lectin receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Inflammatory bowel disease, Rheumatoid arthritis | Mirikizumab
Mirikizumab
💬
|
Mirikizumab
| 3件: 37 37, 96, 97 💬 |
172 |
S1PR5
💬
| 2件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Amiselimod
Amiselimod
💬
|
Amiselimod
| 1件: 97 97 💬 |
173 |
S1PR5
💬
| 2件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Etrasimod
Etrasimod
💬
|
Etrasimod
| 3件: 96 96, 97, 98 💬 |
174 |
S1PR5
💬
| 2件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Ozanimod
Ozanimod
💬
|
Ozanimod
| 3件: 13 13, 96, 97 💬 |
175 |
TLR9
💬
| 9件: Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Salmonella infection, Chagas disease, African trypanosomiasis, Malaria, Tuberculosis, Measles, Herpes simplex virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer | Cobitolimod
Cobitolimod
💬
|
Cobitolimod
| 1件: 97 97 💬 |
176 |
PPARA
💬
| 10件: PPAR signaling pathway PPAR signaling pathway, cAMP signaling pathway, Adipocytokine signaling pathway, Glucagon signaling pathway, Insulin resistance, Non-alcoholic fatty liver disease, Alcoholic liver disease, Hepatitis C, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy | Fenofibrate
Fenofibrate
💬
|
Fenofibrate
| 6件: 8 8, 79, 93, 94, 97, 265 💬 |
177 |
PPARG
💬
| 11件: PPAR signaling pathway PPAR signaling pathway, AMPK signaling pathway, Longevity regulating pathway, Osteoclast differentiation, Thermogenesis, Non-alcoholic fatty liver disease, Huntington disease, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Lipid and atherosclerosis | Rosiglitazone
Rosiglitazone
💬
|
Rosiglitazone
| 5件: 46 46, 75, 97, 222, 265 💬 |
178 |
PPP3CA
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
179 |
PPP3CA
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Cyclosporine
Cyclosporine
💬
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬 |
180 |
PPP3CA
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
181 |
PPP3CB
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
182 |
PPP3CB
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Cyclosporine
Cyclosporine
💬
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬 |
183 |
PPP3CB
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
184 |
PPP3CC
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
185 |
PPP3CC
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Cyclosporine
Cyclosporine
💬
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬 |
186 |
PPP3CC
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
187 |
PPP3R1
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
188 |
PPP3R1
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Cyclosporine
Cyclosporine
💬
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬 |
189 |
PPP3R1
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
190 |
PPP3R2
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
191 |
PPP3R2
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Cyclosporine
Cyclosporine
💬
|
Cyclosporine
| 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬 |
192 |
PPP3R2
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬 |
193 |
PRKAA1
💬
| 20件: FoxO signaling pathway FoxO signaling pathway, Autophagy - animal, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Apelin signaling pathway, Tight junction, Circadian rhythm, Thermogenesis, Insulin signaling pathway, Adipocytokine signaling pathway, Oxytocin signaling pathway, Glucagon signaling pathway, Insulin resistance, Non-alcoholic fatty liver disease, Alcoholic liver disease, Hypertrophic cardiomyopathy, Fluid shear stress and atherosclerosis | Metformin
Metformin
💬
|
Metformin
| 25件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 💬 |
194 |
PRKAA2
💬
| 20件: FoxO signaling pathway FoxO signaling pathway, Autophagy - animal, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Apelin signaling pathway, Tight junction, Circadian rhythm, Thermogenesis, Insulin signaling pathway, Adipocytokine signaling pathway, Oxytocin signaling pathway, Glucagon signaling pathway, Insulin resistance, Non-alcoholic fatty liver disease, Alcoholic liver disease, Hypertrophic cardiomyopathy, Fluid shear stress and atherosclerosis | Metformin
Metformin
💬
|
Metformin
| 25件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 💬 |
195 |
PRKCD
💬
| 17件: Chemokine signaling pathway Chemokine signaling pathway, Autophagy - animal, Vascular smooth muscle contraction, NOD-like receptor signaling pathway, C-type lectin receptor signaling pathway, Fc gamma R-mediated phagocytosis, Neurotrophin signaling pathway, Inflammatory mediator regulation of TRP channels, GnRH signaling pathway, Estrogen signaling pathway, Type II diabetes mellitus, Insulin resistance, AGE-RAGE signaling pathway in diabetic complications, Prion disease, Shigellosis, Chemical carcinogenesis - reactive oxygen species, Diabetic cardiomyopathy | Sotrastaurin
Sotrastaurin
💬
|
Sotrastaurin
| 1件: 97 97 💬 |
196 |
PRKCE
💬
| 13件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, Apelin signaling pathway, Tight junction, Fc gamma R-mediated phagocytosis, Inflammatory mediator regulation of TRP channels, Aldosterone synthesis and secretion, Type II diabetes mellitus, Insulin resistance, AGE-RAGE signaling pathway in diabetic complications, Shigellosis, MicroRNAs in cancer | Sotrastaurin
Sotrastaurin
💬
|
Sotrastaurin
| 1件: 97 97 💬 |
197 |
PRKCH
💬
| 2件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Inflammatory mediator regulation of TRP channels | Sotrastaurin
Sotrastaurin
💬
|
Sotrastaurin
| 1件: 97 97 💬 |
198 |
GABRQ
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
199 |
GABRQ
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Midazolam
Midazolam
💬
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
200 |
GABRQ
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Delorazepam
Delorazepam
💬
|
Delorazepam
| 3件: 6 6, 46, 97 💬 |
201 |
PRKCQ
💬
| 11件: NF-kappa B signaling pathway NF-kappa B signaling pathway, Autophagy - animal, Vascular smooth muscle contraction, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Inflammatory mediator regulation of TRP channels, Adipocytokine signaling pathway, Insulin resistance, Shigellosis, PD-L1 expression and PD-1 checkpoint pathway in cancer | Sotrastaurin
Sotrastaurin
💬
|
Sotrastaurin
| 1件: 97 97 💬 |
202 |
PTGS1
💬
| 5件: Arachidonic acid metabolism Arachidonic acid metabolism, Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | Aspirin
Aspirin
💬
|
Acetylsalicylic acid
| 14件: 13 13, 22, 46, 49, 51, 58, 64, 86, 97, 113, 158, 210, 231, 251 💬 |
203 |
PTGS2
💬
| 22件: Arachidonic acid metabolism Arachidonic acid metabolism, Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, C-type lectin receptor signaling pathway, IL-17 signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Alzheimer disease, Pathways of neurodegeneration - multiple diseases, Leishmaniasis, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Pathways in cancer, Chemical carcinogenesis - DNA adducts, MicroRNAs in cancer, Small cell lung cancer | Aspirin
Aspirin
💬
|
Acetylsalicylic acid
| 14件: 13 13, 22, 46, 49, 51, 58, 64, 86, 97, 113, 158, 210, 231, 251 💬 |
204 |
SCN1A
💬
| 1件: Dopaminergic synapse Dopaminergic synapse | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
205 |
SCN2A
💬
| 1件: Taste transduction Taste transduction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
206 |
SCN3A
💬
| 1件: Taste transduction Taste transduction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
207 |
SCN5A
💬
| 1件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
208 |
SCN9A
💬
| 1件: Taste transduction Taste transduction | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
209 |
SLC5A2
💬
| - | Empagliflozin
Empagliflozin
💬
|
Empagliflozin
| 6件: 58 58, 65, 67, 72, 97, 257 💬 |
210 |
SLC6A2
💬
| 1件: Synaptic vesicle cycle Synaptic vesicle cycle | Phentermine
Phentermine
💬
|
Phentermine
| 1件: 97 97 💬 |
211 |
SLC6A2
💬
| 1件: Synaptic vesicle cycle Synaptic vesicle cycle | Amitriptyline
Amitriptyline
💬
|
Amitriptyline
| 4件: 78 78, 97, 226, 299 💬 |
212 |
SLC6A3
💬
| 7件: Synaptic vesicle cycle Synaptic vesicle cycle, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Alcoholism | Phentermine
Phentermine
💬
|
Phentermine
| 1件: 97 97 💬 |
213 |
SLC6A4
💬
| 2件: Synaptic vesicle cycle Synaptic vesicle cycle, Serotonergic synapse | Phentermine
Phentermine
💬
|
Phentermine
| 1件: 97 97 💬 |
214 |
SLC6A4
💬
| 2件: Synaptic vesicle cycle Synaptic vesicle cycle, Serotonergic synapse | Amitriptyline
Amitriptyline
💬
|
Amitriptyline
| 4件: 78 78, 97, 226, 299 💬 |
215 |
TNF
💬
| 67件: Antifolate resistance Antifolate resistance, MAPK signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, Necroptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, Coronavirus disease - COVID-19, Proteoglycans in cancer, Asthma, Inflammatory bowel disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Thalidomide
Thalidomide
💬
|
Thalidomide
| 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
216 |
TNF
💬
| 67件: Antifolate resistance Antifolate resistance, MAPK signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, Necroptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, Coronavirus disease - COVID-19, Proteoglycans in cancer, Asthma, Inflammatory bowel disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Adalimumab
Adalimumab
💬
|
Adalimumab
| 17件: 19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 💬 |
217 |
TNF
💬
| 67件: Antifolate resistance Antifolate resistance, MAPK signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, Necroptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, Coronavirus disease - COVID-19, Proteoglycans in cancer, Asthma, Inflammatory bowel disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Infliximab
Infliximab
💬
|
Infliximab
| 27件: 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬 |
218 |
TNF
💬
| 67件: Antifolate resistance Antifolate resistance, MAPK signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, Necroptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, Coronavirus disease - COVID-19, Proteoglycans in cancer, Asthma, Inflammatory bowel disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Certolizumab pegol
Certolizumab pegol
💬
|
Certolizumab pegol
| 8件: 37 37, 46, 49, 96, 97, 107, 226, 271 💬 |
219 |
TNF
💬
| 67件: Antifolate resistance Antifolate resistance, MAPK signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, Necroptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, Coronavirus disease - COVID-19, Proteoglycans in cancer, Asthma, Inflammatory bowel disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Golimumab
Golimumab
💬
|
Golimumab
| 8件: 46 46, 56, 84, 96, 97, 107, 270, 271 💬 |
220 |
TPH1
💬
| 4件: Tryptophan metabolism Tryptophan metabolism, Folate biosynthesis, Metabolic pathways, Serotonergic synapse | Telotristat
Telotristat
💬
|
Telotristat
| 1件: 97 97 💬 |
221 |
TYK2
💬
| 16件: Necroptosis Necroptosis, Osteoclast differentiation, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Hepatitis C, Hepatitis B, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19 | Tofacitinib
Tofacitinib
💬
|
Tofacitinib
| 15件: 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬 |
222 |
TYK2
💬
| 16件: Necroptosis Necroptosis, Osteoclast differentiation, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Hepatitis C, Hepatitis B, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19 | Deucravacitinib
Deucravacitinib
💬
|
Deucravacitinib
| 3件: 49 49, 96, 97 💬 |
223 |
VDR
💬
| 5件: Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis, Chemical carcinogenesis - receptor activation | Ergocalciferol
Ergocalciferol
💬
|
Ergocalciferol
| 6件: 46 46, 49, 84, 96, 97, 299 💬 |
224 |
VDR
💬
| 5件: Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis, Chemical carcinogenesis - receptor activation | Cholecalciferol
Cholecalciferol
💬
|
Cholecalciferol
| 24件: 6 6, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬 |
225 |
XDH
💬
| 6件: Purine metabolism Purine metabolism, Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome | Allopurinol
Allopurinol
💬
|
Allopurinol
| 7件: 6 6, 46, 57, 60, 66, 96, 97 💬 |
226 |
CA2
💬
| 7件: Nitrogen metabolism Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation, Collecting duct acid secretion, Gastric acid secretion, Pancreatic secretion, Bile secretion | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
227 |
CA4
💬
| 3件: Nitrogen metabolism Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
228 |
CACNA1C
💬
| 34件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
229 |
CACNA1D
💬
| 35件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cellular senescence, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Tight junction, Circadian entrainment, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Carbohydrate digestion and absorption, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
230 |
CACNA1F
💬
| 27件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
231 |
CACNA1S
💬
| 27件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Topiramate
Topiramate
💬
|
Topiramate
| 6件: 6 6, 97, 140, 144, 156, 193 💬 |
232 |
IL1R2
💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Amoebiasis, Human T-cell leukemia virus 1 infection, Transcriptional misregulation in cancer, Prostate cancer, Fluid shear stress and atherosclerosis | Anakinra
Anakinra
💬
|
Anakinra
| 18件: 2 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬 |
233 |
PDE5A
💬
| 3件: Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway | Caffeine
Caffeine
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
234 |
PDE5A
💬
| 3件: Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway | Caffeine hydrate
Caffeine hydrate
💬
|
Caffeine
| 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬 |
235 |
S1PR4
💬
| 3件: FoxO signaling pathway FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Amiselimod
Amiselimod
💬
|
Amiselimod
| 1件: 97 97 💬 |
236 |
S1PR4
💬
| 3件: FoxO signaling pathway FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Etrasimod
Etrasimod
💬
|
Etrasimod
| 3件: 96 96, 97, 98 💬 |
237 |
S1PR4
💬
| 3件: FoxO signaling pathway FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Ozanimod
Ozanimod
💬
|
Ozanimod
| 3件: 13 13, 96, 97 💬 |
238 |
IL1RL2
💬
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction | Spesolimab
Spesolimab
💬
|
Spesolimab
| 3件: 37 37, 96, 97 💬 |
239 |
CD3D
💬
| 11件: Hematopoietic cell lineage Hematopoietic cell lineage, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Chagas disease, Measles, Human T-cell leukemia virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency | Visilizumab
Visilizumab
💬
|
Visilizumab
| 2件: 96 96, 97 💬 |
240 |
CD3E
💬
| 11件: Hematopoietic cell lineage Hematopoietic cell lineage, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Chagas disease, Measles, Human T-cell leukemia virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency | Visilizumab
Visilizumab
💬
|
Visilizumab
| 2件: 96 96, 97 💬 |
241 |
HTR3B
💬
| 2件: Serotonergic synapse Serotonergic synapse, Taste transduction | Ondansetron
Ondansetron
💬
|
Ondansetron
| 3件: 6 6, 97, 107 💬 |
242 |
CD3G
💬
| 10件: Hematopoietic cell lineage Hematopoietic cell lineage, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Chagas disease, Measles, Human T-cell leukemia virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer | Visilizumab
Visilizumab
💬
|
Visilizumab
| 2件: 96 96, 97 💬 |
243 |
S1PR2
💬
| 2件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Amiselimod
Amiselimod
💬
|
Amiselimod
| 1件: 97 97 💬 |
244 |
S1PR2
💬
| 2件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Etrasimod
Etrasimod
💬
|
Etrasimod
| 3件: 96 96, 97, 98 💬 |
245 |
S1PR2
💬
| 2件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Ozanimod
Ozanimod
💬
|
Ozanimod
| 3件: 13 13, 96, 97 💬 |
246 |
MS4A1
💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage | Rituximab
Rituximab
💬
|
Rituximab
| 48件: 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
247 |
CD80
💬
| 11件: Virion - Adenovirus Virion - Adenovirus, Cell adhesion molecules, Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis | Abatacept
Abatacept
💬
|
Abatacept
| 26件: 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
248 |
CD86
💬
| 13件: Virion - Adenovirus Virion - Adenovirus, Cell adhesion molecules, Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Kaposi sarcoma-associated herpesvirus infection, Transcriptional misregulation in cancer, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis | Abatacept
Abatacept
💬
|
Abatacept
| 26件: 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
249 |
CD40
💬
| 17件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Cell adhesion molecules, Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Malaria, Toxoplasmosis, Human T-cell leukemia virus 1 infection, Epstein-Barr virus infection, Transcriptional misregulation in cancer, Asthma, Autoimmune thyroid disease, Systemic lupus erythematosus, Allograft rejection, Primary immunodeficiency, Viral myocarditis, Lipid and atherosclerosis | Ravagalimab
Ravagalimab
💬
|
Ravagalimab
| 2件: 53 53, 97 💬 |
250 |
NR1H4
💬
| 1件: Bile secretion Bile secretion | Ursodiol
Ursodiol
💬
|
Ursodeoxycholic acid
| 14件: 6 6, 8, 20, 46, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 💬 |